<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">40835900</PMID><DateRevised><Year>2025</Year><Month>09</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2731-4553</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Aug</Month><Day>20</Day></PubDate></JournalIssue><Title>BMC primary care</Title><ISOAbbreviation>BMC Prim Care</ISOAbbreviation></Journal><ArticleTitle>Family physicians' attitudes and practice on screening and prevention of fragility fractures, and shared decision-making with postmenopausal women: a qualitative study in Spain.</ArticleTitle><Pagination><StartPage>260</StartPage><MedlinePgn>260</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">260</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12875-025-02966-z</ELocationID><Abstract><AbstractText Label="BACKGROUND">Osteoporosis is a prevalent condition among postmenopausal women, significantly increasing the risk of fragility fractures. Despite the availability of clinical guidelines, their implementation in primary care, remains highly variable, particularly regarding fracture prevention and shared decision-making (SDM).</AbstractText><AbstractText Label="METHODS">We conducted a qualitative study to explore the attitudes and practices of Spanish family physicians in preventing fractures among postmenopausal women. Sixteen&#xa0;semi-structured interviews were conducted with physicians from diverse socioeconomic backgrounds and levels of clinical experience. Data were analysed using an iterative, theory-driven approach to identify key themes and barriers.</AbstractText><AbstractText Label="RESULTS">Physicians showed substantial variability in fracture risk assessment approaches, frequently combining tools such as FRAX with clinical judgment. Most were cautious about prescribing bisphosphonates for primary prevention, citing concerns about the strength of the evidence and potential adverse effects. While non-pharmacological strategies, such as lifestyle modifications and fall prevention, were emphasized, their implementation was often constrained by workload pressures. Patient involvement in decision-making was hindered by widespread misconceptions about osteoporosis and&#xa0;its treatment, as well as the lack of appropriate decision-support tools. Participants highlighted the need for clearer guidelines, enhanced educational resources, and accessible decision aids to facilitate patient engagement in care.</AbstractText><AbstractText Label="CONCLUSIONS">This study highlights the complex challenges family physicians face in fracture prevention among postmenopausal women, including heterogeneity of recommendations in guidelines, limited SDM implementation, and systemic barriers within primary care. Addressing these issues will require multifaceted interventions targeting both healthcare system constraints and patient education. Future efforts should focus on developing and implementing strategies that support evidence-based, patient-centred decision-making while accounting for the realities of primary care practice.</AbstractText><AbstractText Label="SUPPLEMENTARY INFORMATION">The online version contains supplementary material available at 10.1186/s12875-025-02966-z.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Le&#xf3;n-Garc&#xed;a</LastName><ForeName>Montserrat</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Iberoamerican Cochrane Centre, Sant Antoni Maria Claret, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Obstetrics, Gynaecology and Preventive Medicine, Universidad Aut&#xf3;noma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Knowledge and Evaluation Research Unit, Department of Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;nez</LastName><ForeName>Esther C&#xe1;novas</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>Institut de Recerca Sant Pau (IR SANT PAU), Sant Quint&#xed; 77-79, Barcelona, 08041, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Servicio de Epidemiolog&#xed;a, Hospital de la Santa Creu i Sant Pau, Sant Antoni Maria Claret 167, Barcelona, 08025, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xe9;rez</LastName><ForeName>Yolanda &#xc1;lvarez</ForeName><Initials>Y&#xc1;</Initials><AffiliationInfo><Affiliation>Canary Islands Health Research Institute Foundation (FIISC), Las Palmas de Gran Canaria, Tenerife, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Evaluation Unit (SESCS), Canary Islands Health Service (SCS), El Rosario, Tenerife, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Network for Research on Chronicity, Primary Care and Health Promotion (RICAPPS), Basque, Tenerife, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pou</LastName><ForeName>Mar&#xed;a Antonia</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Equipo de Atenci&#xf3;n Primaria Encants, Institut Catal&#xe0; de la Salut, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>GREMPAL (Grup de recerca en Malalties prevalents de l'aparell locomotor), Institut d'Investigaci&#xf3; en AP J Gol, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departament de Medicina, Universitat Aut&#xf2;noma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-Franco</LastName><ForeName>Alberto L&#xf3;pez</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Equipo de Atenci&#xf3;n Primaria "Doctor Mendiguch&#xed;a Carriche" Leganes, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Programa de Actividades Preventivas y Promoci&#xf3;n de la Salud (PAPPS) de la Sociedad Espa&#xf1;ola de Medicina Familiar y Comunitaria (SEMFYC), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bas</LastName><ForeName>Ana Sanz</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Departament de Medicina, Universitat Aut&#xf2;noma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Horta Primary Health Care Centre, Institut Catal&#xe0; de la Salut, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez-Moreno</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, Universidad Villanueva, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Espinoza</LastName><ForeName>Claudia Erika Delgado</ForeName><Initials>CED</Initials><AffiliationInfo><Affiliation>Department of Clinical Pharmacology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacology, Therapeutics and Toxicology, Universitat Aut&#xf2;noma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roca</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, Universidad Villanueva, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osuna</LastName><ForeName>Ar&#xe1;nzazu Gonz&#xe1;lez</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Departament de Medicina, Universitat Aut&#xf2;noma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Equipo Atenci&#xf3;n primaria Guinard&#xf3; Barcelona, Institut Catal&#xe0; de la Salut, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Orthopaedic and Traumatology Surgery Service, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valverde</LastName><ForeName>Diana Fern&#xe1;ndez</ForeName><Initials>DF</Initials><AffiliationInfo><Affiliation>Institut de Recerca Sant Pau (IR SANT PAU), Sant Quint&#xed; 77-79, Barcelona, 08041, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vallcarca-Sant Gervasi Primary Health Care Research Unit, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universitat Rovira i Virgili, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nanco</LastName><ForeName>Betzabeth Mar&#xed;n</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Universidad Santo Tomas, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Medina-Aedo</LastName><ForeName>Melixa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Iberoamerican Cochrane Centre, Sant Antoni Maria Claret, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Obstetrics, Gynaecology and Preventive Medicine, Universidad Aut&#xf3;noma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut de Recerca Sant Pau (IR SANT PAU), Sant Quint&#xed; 77-79, Barcelona, 08041, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perestelo-P&#xe9;rez</LastName><ForeName>Lilisbeth</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Evaluation Unit (SESCS), Canary Islands Health Service (SCS), El Rosario, Tenerife, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Network for Research on Chronicity, Primary Care and Health Promotion (RICAPPS), Basque, Tenerife, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alonso-Coello</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institut de Recerca Sant Pau (IR SANT PAU), Sant Quint&#xed; 77-79, Barcelona, 08041, Spain. PAlonso@santpau.cat.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (CIBERESP), Madrid, Spain. PAlonso@santpau.cat.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PI20/00681</GrantID><Agency>Health Institute Carlos III and Co-funded by the European Regional Development Fund "A way to make Europe"</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Prim Care</MedlineTA><NlmUniqueID>9918300889006676</NlmUniqueID><ISSNLinking>2731-4553</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Fragility fractures</Keyword><Keyword MajorTopicYN="N">Osteoporosis</Keyword><Keyword MajorTopicYN="N">Primary healthcare</Keyword><Keyword MajorTopicYN="N">Primary prevention</Keyword><Keyword MajorTopicYN="N">Shared decision-making</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: The study adhered to the World Medical Association Declaration of Helsinki and the Ethics Committee of the Hospital Sant Pau, Barcelona, Spain, waived the need for ethics approval for this study (Ref: IIBSP-TDC-2021-22). All participants gave written informed consent to participate. Consent for publication: All participants gave written informed consent for publication. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>21</Day><Hour>0</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>21</Day><Hour>0</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>20</Day><Hour>23</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>8</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40835900</ArticleId><ArticleId IdType="pmc">PMC12366220</ArticleId><ArticleId IdType="doi">10.1186/s12875-025-02966-z</ArticleId><ArticleId IdType="pii">10.1186/s12875-025-02966-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Qaseem A, Forciea MA, McLean RM, Denberg TD, for the Clinical Guidelines Committee of the American College of Physicians*. Treatment of low bone density or osteoporosis to prevent fractures in men and women: A clinical practice guideline update from the American College of Physicians. Ann Intern Med. 2017;166(11):818&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">28492856</ArticleId></ArticleIdList></Reference><Reference><Citation>Naranjo Hern&#xe1;ndez A, D&#xed;az D, Campo Fontecha P, Aguado Ac&#xed;n MP, Arboleya Rodr&#xed;guez L, Casado Burgos E, Casta&#xf1;eda S, et al. Recomendaciones de la Sociedad Espa&#xf1;ola de Reumatolog&#xed;a sobre osteoporosis. Reumatol Cl&#xed;nica. 2019;15(4):188&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pubmed">30470636</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernlund E, Svedbom A, Iverg&#xe5;rd M, Compston J, Cooper C, Stenmark J, et al. Osteoporosis in the European union: medical management, epidemiology and economic burden: A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos. 2013;8(1&#x2013;2):136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3880487</ArticleId><ArticleId IdType="pubmed">24113837</ArticleId></ArticleIdList></Reference><Reference><Citation>Borgstr&#xf6;m F, Karlsson L, Orts&#xe4;ter G, Norton N, Halbout P, Cooper C, et al. Fragility fractures in europe: burden, management and opportunities. Arch Osteoporos. 2020;15(1):59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7166207</ArticleId><ArticleId IdType="pubmed">32306163</ArticleId></ArticleIdList></Reference><Reference><Citation>Arribas D, Ben&#xed;tez D, Carbonell C, Cebamanos J, del Rio L. Gu&#xed;a de Pr&#xe1;ctica Cl&#xed;nica sobre Osteoporosis y Prevenci&#xf3;n de Fracturas por Fragilidad [Internet]. SNS; [cited 2024 Jan 10]. Available from: http://www.guiasalud.es/GPC/GPC_476_Osteoporosis_AIAQS_compl.pdf. </Citation></Reference><Reference><Citation>Mart&#xed;nez-Laguna D, Carbonell C, Bastida JC, Gonz&#xe1;lez M, Mic&#xf3;-P&#xe9;rez RM, Vargas F, et al. Prevalence and treatment of fragility fractures in Spanish primary care: prefraos study. Arch Osteoporos. 2022;17(1):93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9283348</ArticleId><ArticleId IdType="pubmed">35836031</ArticleId></ArticleIdList></Reference><Reference><Citation>Caeiro JR, Bartra A, Mesa-Ramos M, Etxebarr&#xed;a &#xcd;, Montejo J, Carpintero P, et al. Burden of first osteoporotic hip fracture in Spain: a prospective, 12-month, observational study. Calcif Tissue Int. 2017;100(1):29&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5214753</ArticleId><ArticleId IdType="pubmed">27738719</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanis JA, Cooper C, Rizzoli R, Reginster JY, Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF). European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. 2019;30(1):3&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7026233</ArticleId><ArticleId IdType="pubmed">30324412</ArticleId></ArticleIdList></Reference><Reference><Citation>Etxebarria-Foronda I, Caeiro-Rey JR, Larrainzar-Garijo R, Vaquero-Cervino E, Roca-Ruiz L, Mesa-Ramos M, et al. Gu&#xed;a SECOT-GEIOS en osteoporosis y fractura por fragilidad. Actualizaci&#xf3;n Rev Esp Cir Ortop&#xe9;dica Traumatol. 2015;59(6):373&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">26233814</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez Garc&#xed;a-Franco A, Baeyens Fern&#xe1;ndez JA, Iglesias Pi&#xf1;eiro MJ, Alonso Coello P, Ruiz Cabello C, Pereira Iglesias A, et al. Actividades preventivas En La mujer. Actualizaci&#xf3;n PAPPS 2022. Aten Primaria. 2022;54: 102471.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9705224</ArticleId><ArticleId IdType="pubmed">36435585</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghirardi A, Di Bari M, Zambon A, Scotti L, Della Vedova G, Lapi F, et al. Effectiveness of oral bisphosphonates for primary prevention of osteoporotic fractures: evidence from the AIFA-BEST observational study. Eur J Clin Pharmacol. 2014;70(9):1129&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">24951915</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen F, Du H, Ding L, Hu J, Huang Z, Huang H, et al. Clinical efficacy and safety of drug interventions for primary and secondary prevention of osteoporotic fractures in postmenopausal women: network meta-analysis followed by factor and cluster analysis. PLoS One. 2020;15(6): e0234123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7269244</ArticleId><ArticleId IdType="pubmed">32492050</ArticleId></ArticleIdList></Reference><Reference><Citation>Real J, Galindo G, Galv&#xe1;n L, Lafarga MA, Rodrigo MD, Ortega M. Use of Oral Bisphosphonates in Primary Prevention of Fractures in Postmenopausal Women: A Population-Based Cohort Study.&#xa0;Carvajal A, editor. PLoS One. 2015;10(4):e0118178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4393307</ArticleId><ArticleId IdType="pubmed">25861000</ArticleId></ArticleIdList></Reference><Reference><Citation>Sale JEM, Marwah A, Naeem F, Yu W, Meadows L. Evidence of patient beliefs, values, and preferences is not provided in osteoporosis clinical practice guidelines. Osteoporos Int. 2019;30(7):1325&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">30859238</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayawi LM, Graham ID, Tugwell P, Yousef Abdelrazeq S. Screening for osteoporosis: A systematic assessment of the quality and content of clinical practice guidelines, using the AGREE II instrument and the IOM Standards for Trustworthy Guidelines. Williams BO, editor. PLoS One. 2018;13(12):e0208251.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6283636</ArticleId><ArticleId IdType="pubmed">30521556</ArticleId></ArticleIdList></Reference><Reference><Citation>Medina-Aedo M, Arauz I, G&#xfc;nther M, Menai SD, Gregorio S, Le&#xf3;n-Garc&#xed;a M et al. Incorporating women&#x2019;s perspectives into osteoporosis clinical guidelines: A systematic evaluation. 2023 [cited 2023 Dec 5]; Available from: https://osf.io/udres/. </Citation><ArticleIdList><ArticleId IdType="pubmed">39029540</ArticleId></ArticleIdList></Reference><Reference><Citation>Montori VM, Shah ND, Pencille LJ, Branda ME, Van Houten HK, Swiglo BA, et al. Use of a decision aid to improve treatment decisions in osteoporosis: the osteoporosis choice randomized trial. Am J Med. 2011;124(6):549&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">21605732</ArticleId></ArticleIdList></Reference><Reference><Citation>Cranney A, O&#x2019;Connor AM, Jacobsen MJ, Tugwell P, Adachi JD, Ooi DS, et al. Development and pilot testing of a decision aid for postmenopausal women with osteoporosis. Patient Educ Couns. 2002;47(3):245&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">12088603</ArticleId></ArticleIdList></Reference><Reference><Citation>Paskins Z, Torres Roldan VD, Hawarden AW, Bullock L, Meritxell Urtecho S, Torres GF, et al. Quality and effectiveness of osteoporosis treatment decision aids: a systematic review and environmental scan. Osteoporos Int. 2020;31(10):1837&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">32500301</ArticleId></ArticleIdList></Reference><Reference><Citation>Gravel K, L&#xe9;gar&#xe9; F, Graham ID. Barriers and facilitators to implementing shared decision-making in clinical practice: a systematic review of health professionals&#x2019; perceptions. Implement Sci. 2006;1(1):16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1586024</ArticleId><ArticleId IdType="pubmed">16899124</ArticleId></ArticleIdList></Reference><Reference><Citation>Merle B, Haesebaert J, Bedouet A, Barraud L, Flori M, Schott AM, et al. Osteoporosis prevention: Where are the barriers to improvement in French general practitioners? A qualitative study. Oelke N, editor. PLoS ONE. 2019;14(7):e0219681.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6634405</ArticleId><ArticleId IdType="pubmed">31310619</ArticleId></ArticleIdList></Reference><Reference><Citation>Busetto L, Wick W, Gumbinger C. How to use and assess qualitative research methods. Neurol Res Pract. 2020;2(1):14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7650082</ArticleId><ArticleId IdType="pubmed">33324920</ArticleId></ArticleIdList></Reference><Reference><Citation>Green J, Thorogood N. Qualitative methods for health research. 4th ed. Los Angeles London New Delhi: SAGE; 2018. p. 420.</Citation></Reference><Reference><Citation>Elo S, Kyng&#xe4;s H. The qualitative content analysis process. J Adv Nurs. 2008;62(1):107&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">18352969</ArticleId></ArticleIdList></Reference><Reference><Citation>McHugh ML. Interrater reliability: the kappa statistic. Biochem Med. 2012;22(3):276&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3900052</ArticleId><ArticleId IdType="pubmed">23092060</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnett-Page E, Thomas J. Methods for the synthesis of qualitative research: a critical review. BMC Med Res Methodol. 2009;9(1):59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3224695</ArticleId><ArticleId IdType="pubmed">19671152</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">17872937</ArticleId></ArticleIdList></Reference><Reference><Citation>Bullock L, Manning F, Hawarden A, Fleming J, Leyland S, Clark EM, et al. Exploring practice and perspectives on shared decision-making about osteoporosis medicines in fracture liaison services: the iFraP development qualitative study. Arch Osteoporos. 2024;19(1):50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11186902</ArticleId><ArticleId IdType="pubmed">38898212</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett MJ, Center JR, Perry L. Exploring barriers and opportunities to improve osteoporosis care across the acute-to-primary care interface: a qualitative study. Osteoporos Int. 2023;34(7):1249&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10281902</ArticleId><ArticleId IdType="pubmed">37093239</ArticleId></ArticleIdList></Reference><Reference><Citation>Naranjo A, Ojeda S, Giner M, Balcells-Oliver M, Canals L, Cancio JM, et al. Best practice framework of fracture liaison services in Spain and their coordination with primary care. Arch Osteoporos. 2020;15(1):63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7183494</ArticleId><ArticleId IdType="pubmed">32335759</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39029540</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-5921</ISSN><JournalIssue CitedMedium="Internet"><Volume>173</Volume><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of clinical epidemiology</Title><ISOAbbreviation>J Clin Epidemiol</ISOAbbreviation></Journal><ArticleTitle>Incorporating postmenopausal women's perspectives into osteoporosis clinical guidelines: a systematic review.</ArticleTitle><Pagination><StartPage>111468</StartPage><MedlinePgn>111468</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jclinepi.2024.111468</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0895-4356(24)00224-5</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To assess the inclusion of individuals' perspectives in the development of osteoporosis Clinical Practice Guidelines (CPGs) for primary fracture prevention in postmenopausal women.</AbstractText><AbstractText Label="STUDY DESIGN AND SETTING" NlmCategory="METHODS">We performed a comprehensive systematic search across guideline databases and (CPGs) developing organizations websites. Using the AGREE II tool, we assessed the quality of the guidelines, with particular emphasis on the inclusion of patients, or representatives in the development process. We also examined if women's perspectives were considered at the recommendations level and explored the potential association between the inclusion of patients' values and preferences with the quality of the CPGs.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We retrieved a total of 491 eligible CPGs, of which 33 were finally included. The majority of the CPGs were developed by scientific societies (63.6%), primarily from Europe (39.4%) and North America (30.3%). One in every four (24.2%) guidelines explicitly included individuals' perspectives in their development, and one in ten (12.1%) included research evidence about this aspect to support their recommendations. The domains with the lowest mean scores in the quality assessment were applicability (42.4%), rigor of development (44.7%), and stakeholder involvement (45.7%), and 61% were recommended for use according to our assessment. Guidelines of higher quality were more likely to include women's perspective in their development (mean difference 39.31, P&#xa0;=&#xa0;.003).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The incorporation of women's perspectives into the process of developing guidelines for primary fracture prevention in osteoporosis remains inadequate. Our findings serve as a call for guideline developers to improve this situation, and for users, and policymakers to be aware of these limitations, when using or implementing guidelines in this field.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Medina-Aedo</LastName><ForeName>Melixa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institut de Recerca Sant Pau (IR SANT PAU), Sant Quint&#xed;, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xfc;nther</LastName><ForeName>Mat&#xed;as</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Universidad de Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arauz</LastName><ForeName>Ibell</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Universitat Aut&#xf2;noma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Domancic</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Departamento de Cirugia y Traumatologia Bucal y Maxilofacial, Universidad de Chile, Santiago, Chile; Hospital Santiago Oriente Dr. Luis Tisn&#xe9; Brousse, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diaz-Menai</LastName><ForeName>Samanta</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Programa de residencias, Ministerio de Salud de la Provincia de Buenos Aires, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gregorio</LastName><ForeName>Sofia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Programa de residencias, Ministerio de Salud de la Provincia de Buenos Aires, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le&#xf3;n-Garc&#xed;a</LastName><ForeName>Montserrat</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institut de Recerca Sant Pau (IR SANT PAU), Sant Quint&#xed;, Barcelona, Spain; Knowledge and Evaluation Research Unit, Department of Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santero</LastName><ForeName>Marilina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institut de Recerca Sant Pau (IR SANT PAU), Sant Quint&#xed;, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pardo-Hernadez</LastName><ForeName>Hector</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institut de Recerca Sant Pau (IR SANT PAU), Sant Quint&#xed;, Barcelona, Spain; Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (CIBERESP), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alonso-Coello</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institut de Recerca Sant Pau (IR SANT PAU), Sant Quint&#xed;, Barcelona, Spain; Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (CIBERESP), Madrid, Spain; Programa de Actividades Preventivas y de Promoci&#xf3;n de la Salud (PAPPS), Sociedad Espa&#xf1;ola de Medicina de Familia y Comunitaria (semFYC), Barcelona, Spain. Electronic address: PAlonso@santpau.cat.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Epidemiol</MedlineTA><NlmUniqueID>8801383</NlmUniqueID><ISSNLinking>0895-4356</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="Y">Practice Guidelines as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015663" MajorTopicYN="Y">Osteoporosis, Postmenopausal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017698" MajorTopicYN="N">Postmenopause</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058866" MajorTopicYN="N">Osteoporotic Fractures</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Guideline as a topic</Keyword><Keyword MajorTopicYN="N">Osteoporosis</Keyword><Keyword MajorTopicYN="N">Patient participation</Keyword><Keyword MajorTopicYN="N">Patient preference</Keyword><Keyword MajorTopicYN="N">Practice guidelines as topic</Keyword><Keyword MajorTopicYN="N">Primary prevention</Keyword></KeywordList><CoiStatement>Declaration of competing interest There are no competing interests for any author.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>6</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>3</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>20</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>19</Day><Hour>19</Hour><Minute>28</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39029540</ArticleId><ArticleId IdType="doi">10.1016/j.jclinepi.2024.111468</ArticleId><ArticleId IdType="pii">S0895-4356(24)00224-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36442354</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>06</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1578-1275</ISSN><JournalIssue CitedMedium="Internet"><Volume>55</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Atencion primaria</Title><ISOAbbreviation>Aten Primaria</ISOAbbreviation></Journal><ArticleTitle>[Will the new drugs be able to curb the global epidemic of obesity and overweight?].</ArticleTitle><Pagination><StartPage>102518</StartPage><MedlinePgn>102518</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">102518</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.aprim.2022.102518</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0212-6567(22)00238-4</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Camarelles Guillem</LastName><ForeName>Francisco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Presidente del Organismo de Coordinaci&#xf3;n del Programa de Actividades Preventivas y Promoci&#xf3;n de la Salud PAPPS de semFYC, Espa&#xf1;a. Electronic address: fcamarelles@telefonica.net.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList><VernacularTitle>&#xbf;Podr&#xe1;n los nuevos f&#xe1;rmacos frenar la epidemia mundial de la obesidad y el sobrepeso?</VernacularTitle><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Aten Primaria</MedlineTA><NlmUniqueID>9111075</NlmUniqueID><ISSNLinking>0212-6567</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050177" MajorTopicYN="Y">Overweight</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="Y">Obesity</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>28</Day><Hour>18</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36442354</ArticleId><ArticleId IdType="pmc">PMC9706127</ArticleId><ArticleId IdType="doi">10.1016/j.aprim.2022.102518</ArticleId><ArticleId IdType="pii">S0212-6567(22)00238-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bl&#xfc;her M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019;15:288&#x2013;298. doi: 10.1038/s41574-019-0176-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-019-0176-8</ArticleId><ArticleId IdType="pubmed">30814686</ArticleId></ArticleIdList></Reference><Reference><Citation>Sturgiss E., Jay M., Campbell-Scherer D., Van Weel C. Challenging assumptions in obesity research. BMJ. 2017;359:j5303. doi: 10.1136/bmj.j5303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.j5303</ArticleId><ArticleId IdType="pubmed">29167093</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinburn B.A., Kraak V.I., Allender S., Atkins V.J., Baker P.I., Bogard J.R., et al. The Global Syndemic of Obesity, Undernutrition, and Climate Change: The Lancet Commission report. Lancet. 2019;393:791&#x2013;846. doi: 10.1016/S0140-6736(18)32822-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(18)32822-8</ArticleId><ArticleId IdType="pubmed">30700377</ArticleId></ArticleIdList></Reference><Reference><Citation>Aranceta-Bartrina J., P&#xe9;rez-Rodrigo C., Alberdi-Aresti G., Ramos-Carrera N., L&#xe1;zaro-Masedo S. Prevalencia de obesidad general y obesidad abdominal en la poblaci&#xf3;n adulta espa&#xf1;ola (25-64 a&#xf1;os) 2014-2015: estudio ENPE. Rev Esp Cardiol. 2016;69:579&#x2013;587. doi: 10.1016/j.recesp.2016.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.recesp.2016.02.010</ArticleId><ArticleId IdType="pubmed">27133458</ArticleId></ArticleIdList></Reference><Reference><Citation>Romaguera M. Alimentaci&#xf3;n, Actividad f&#xed;sica, Desarrollo Infantil y Obesidad en Espa&#xf1;a (ALADINO 2019). Blog Salud y Prevenci&#xf3;n PAPPS; 8 enero 2021. Disponible en https://educacionpapps.blogspot.com/2021/01/alimentacion-actividad-fisica.html</Citation></Reference><Reference><Citation>Bravo-Saquicela D.M., Sabag A., Rezende L.F.M., Rey-Lopez J.P. Has the Prevalence of Childhood Obesity in Spain Plateaued? A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2022;19:5240. doi: 10.3390/ijerph19095240.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19095240</ArticleId><ArticleId IdType="pmc">PMC9105543</ArticleId><ArticleId IdType="pubmed">35564634</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez-Puente J. &#xbf;Qu&#xe9; le digo a un paciente que quiere perder peso? Blog Salud y Prevenci&#xf3;n PAPPS; 8 febrero 2018. Disponible en http://educacionpapps.blogspot.com/2018/02/que-le-digo-un-paciente-que-quiere.html</Citation></Reference><Reference><Citation>Perreault L. Obesity in adults: Drug therapy. In UpToDate Pi-Sunyer (E), UpToDate Givens J [consultado 20 Oct 2022]. Disponible en https://www-uptodate-com.bvcscm.a17.csinet.es/contents/obesity-in-adults-drug-therapy?sectionName=OUR%20APPROACH&amp;search=OBESITY&amp;topicRef=5371&amp;anchor= H3&amp;source=see_link#H3</Citation></Reference><Reference><Citation>Grunvald E., Shah R., Hernaez R., Chandar A.K., Pickett-Blakely O., Teigen L.M., et al. AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity. Gastroenterology. 2022;163:1198&#x2013;1225. doi: 10.1053/j.gastro.2022.08.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2022.08.045</ArticleId><ArticleId IdType="pubmed">36273831</ArticleId></ArticleIdList></Reference><Reference><Citation>Jastreboff A.M., Aronne L.J., Ahmad N.N., Wharton S., Connery L., Alves B., et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387:205&#x2013;216. doi: 10.1056/NEJMoa2206038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2206038</ArticleId><ArticleId IdType="pubmed">35658024</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter S., Mej&#xed;a-Guevara I., Estrada K., Liu S.Y., Glymour M.M. Association of a Genetic Risk Score with Body Mass Index Across Different Birth Cohorts. JAMA. 2016;316:63&#x2013;69. doi: 10.1001/jama.2016.8729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.8729</ArticleId><ArticleId IdType="pubmed">27380344</ArticleId></ArticleIdList></Reference><Reference><Citation>Organizaci&#xf3;n Mundial de la Salud. The World Obesity Federation (World Obesity) 2022. STOP Project and WHO publish six new briefings [consultado 20 Oct 2022]. Disponible en https://www.worldobesity.org/news/publication-of-who-briefings</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34620817</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2173-9110</ISSN><JournalIssue CitedMedium="Internet"><Volume>95</Volume><PubDate><Year>2021</Year><Month>Oct</Month><Day>08</Day></PubDate></JournalIssue><Title>Revista espanola de salud publica</Title><ISOAbbreviation>Rev Esp Salud Publica</ISOAbbreviation></Journal><ArticleTitle>[Vision of the management of frailty in Primary Health Care.].</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e202110159</ELocationID><Abstract><AbstractText>Primary Care (PC) and community are the priority health sites for the detection and management of frailty. There are good guidelines (Strategy and consensus of the National Health Service, ADVANTAGE European Joint Action, recommendations of the Program of Prevention and Health Promotion Activities of the Spanish Society of Family and Community Medicine PAPPS-semFYC, Fisterra guideline); however, its implementation is not taking place with the expected magnitude or speed, also considering the influence of the COVID-19 pandemic. The detection and management of frailty requires multidisciplinary work by professionals who usually carry out their activity at the first level of care (physicians, nurses, social workers), with others whose integration is advisable (nutritionists, physiotherapists, etc.); and counting on others of reference (geriatricians). On the other hand, it is necessary to work with comprehensive approaches based on good coordination between PC and the Community, with various experiences in this regard. The support by the Information and Communication Technologies (ICT) can be very interesting, with tools for both users and careers (e.g., VIVIFRAIL), as well as for social and health professionals (e.g., VALINTAN or WHO ICOPE-Handbook App). Strategies to intervene in fragility in a more effective and systematic way must be consolidated: with an adequate professional training, establishment of campaigns and dissemination ways for visualizing its relevance and extend their intervention, prioritization of the most effective programmed assistance activities (highlighting fragility), multidisciplinary work with coordination and participation of the different healthcare and community levels and of the patients themselves, and providing the PC with adequate resources.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Martin Lesende</LastName><ForeName>I&#xf1;aki</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Centro de Salud Indautxu. Organizaci&#xf3;n Sanitaria Integrada Bilbao-Basurto-Osakidetza. Profesor del Departamento de Medicina de la Universidad del Pa&#xed;s Vasco (UPV/EHU). Representante de la Sociedad Espa&#xf1;ola de Medicina Familiar y Comunitaria (semFYC) en el Grupo de Trabajo de fragilidad del Ministerio de Sanidad. Espa&#xf1;a.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Grupo de Trabajo semFYC del Mayor y de Prevenci&#xf3;n en el Mayor del Programa de Actividades Preventivas y de Promoci&#xf3;n de la Salud (PAPPS). Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Acosta Benito</LastName><ForeName>Miguel &#xc1;ngel</ForeName><Initials>M&#xc1;</Initials><AffiliationInfo><Affiliation>Grupo de Trabajo semFYC del Mayor y de Prevenci&#xf3;n en el Mayor del Programa de Actividades Preventivas y de Promoci&#xf3;n de la Salud (PAPPS). Espa&#xf1;a.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Salud de Joaqu&#xed;n Rodrigo. Madrid. Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Go&#xf1;i Ruiz</LastName><ForeName>Nuria</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Servicio de Apoyo a la Gesti&#xf3;n Cl&#xed;nica y Continuidad Asistencial. Gerencia Atenci&#xf3;n Primaria. Servicio Navarro de Salud-Osasunbidea. Grado de Medicina de la Universidad P&#xfa;blica de Navarra. Pamplona. Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herreros Herreros</LastName><ForeName>Yolanda</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Centro de Salud de Numancia. Institut Catal&#xe0; de la Salut (ICS). Servei d'Atenci&#xf3; Prim&#xe0;ria (SAP) SAP Esquerra. Grupo de Trabajo Gent Gran de la Sociedad Catalana de Medicina Familiar y Comunitaria (CAMFIC).Barcelona. Espa&#xf1;a.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Visi&#xf3;n del manejo de la fragilidad en Atenci&#xf3;n Primaria.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Rev Esp Salud Publica</MedlineTA><NlmUniqueID>9600212</NlmUniqueID><ISSNLinking>1135-5727</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073496" MajorTopicYN="Y">Frailty</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011320" MajorTopicYN="N">Primary Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013222" MajorTopicYN="N">State Medicine</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText>La Atenci&#xf3;n Primaria (AP) y la comunidad constituyen el medio asistencial primordial para el manejo de la fragilidad. Se cuenta con buenas directrices (Estrategia y Consenso del Sistema Nacional de Salud, Acci&#xf3;n Conjunta Europea ADVANTAGE, recomendaciones del Programa de Actividades de Prevenci&#xf3;n y de Promoci&#xf3;n de la Salud de la Sociedad Espa&#xf1;ola de Medicina familiar y Comunitaria: PAPPS-semFYC, gu&#xed;a Fisterra...); no obstante, su implantaci&#xf3;n no se est&#xe1; dando con la magnitud ni rapidez esperada, considerando tambi&#xe9;n la influencia de la pandemia por la COVID-19. La detecci&#xf3;n y manejo de la fragilidad exige un trabajo multidisciplinar de profesionales que habitualmente desarrollan su actividad en el primer nivel asistencial (profesionales de medicina, enfermer&#xed;a y trabajo social), junto con otros cuya integraci&#xf3;n es aconsejable (nutricionistas, fisioterapeutas, etc...) y contando con otros profesionales de referencia (geriatras). Por otro lado, es necesario trabajar con enfoques integrales basados en una buena coordinaci&#xf3;n entre AP y la Comunidad, existiendo diversas experiencias en este sentido. El apoyo de las Tecnolog&#xed;as de la Informaci&#xf3;n y Comunicaci&#xf3;n (TIC) puede ser muy interesante, existiendo herramientas tanto para usuarios y personas cuidadoras (por ej. VIVIFRAIL), como para profesionales sociosanitarios (por ej. VALINTAN o WHO ICOPE-Handbook App). Deben consolidarse las estrategias para intervenir en fragilidad de una manera m&#xe1;s efectiva y sistem&#xe1;tica: con la formaci&#xf3;n adecuada de los profesionales, establecimiento de campa&#xf1;as y difusi&#xf3;n que hagan visualizar la relevancia y extender su intervenci&#xf3;n, priorizando las actividades asistenciales programadas m&#xe1;s efectivas (destacando la fragilidad), a trav&#xe9;s del trabajo multidisciplinar con coordinaci&#xf3;n y participaci&#xf3;n de los diferentes niveles asistenciales y comunitarios y de los propios pacientes, y dotando de medios y recursos a la AP.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aged</Keyword><Keyword MajorTopicYN="N">Frailty</Keyword><Keyword MajorTopicYN="N">Health services</Keyword><Keyword MajorTopicYN="N">Primary Health care</Keyword><Keyword MajorTopicYN="N">Spain</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>8</Day><Hour>6</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34620817</ArticleId><ArticleId IdType="pii">e202110159</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33388114</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>29</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1578-1275</ISSN><JournalIssue CitedMedium="Internet"><Volume>52 Suppl 2</Volume><Issue>Suppl 2</Issue><PubDate><Year>2020</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Atencion primaria</Title><ISOAbbreviation>Aten Primaria</ISOAbbreviation></Journal><ArticleTitle>[Analysis of the situation, evaluation and improvement proposals of the Preventive Activities and Health Promotion Program (PAPPS)].</ArticleTitle><Pagination><StartPage>161</StartPage><EndPage>172</EndPage><MedlinePgn>161-172</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.aprim.2020.09.002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0212-6567(20)30281-X</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To analyze the situation, evaluation and proposals for improvement of the Preventive Activities and Health Promotion Program (PAPPS).</AbstractText><AbstractText Label="MATERIAL AND METHODS">A qualitative study of situation analysis was carried out for the evaluation of the PAPPS in 2 phases: 1) Generation of ideas and collection of information through a DAFO matrix, using 2 types of criteria: internal (strengths and weaknesses), and external (threats and opportunities); 2) Prioritization of the improvement proposals collected. Selection of participants: Key informants were identified taking into account their relationship and knowledge of the PAPPS program. All members of the PAPPS, expert groups and members with past participation were included, as well as the coordinators, including the autonomous leaders of the PAPPS. Two invitations to participate in the study were sent: the first from December 29, 2017 to February 11, 2018, and the second from January 10 to 23, 2019. The information was obtained from a questionnaire designed to be self-completed.</AbstractText><AbstractText Label="RESULTS AND CONCLUSIONS">A total of 73 subjects answered the questionnaire. 35% of the participants were members of the PAPPS working groups, followed by family doctors from other areas, with 20.5%. The order of prioritization of the improvement proposals was as follows: 1) Unify recommendations with other semFYC working groups; 2) Prepare lists with "Recommendations not to do" from the point of view of prevention; 3) Incorporate PAPPS in the political agenda; 4) Greater coordination and interaction between groups with common competences; 5) Teaching in undergraduate and teaching units; 6) Review, update and dissemination of the program in Primary Care.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 The Authors. Publicado por Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mart&#xed;n-Carrillo Dom&#xed;nguez</LastName><ForeName>Pilar</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Grupo de evaluaci&#xf3;n y mejora del PAPPS (semFYC).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;n-Rabad&#xe1;n Muro</LastName><ForeName>Mar&#xed;a</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Grupo de evaluaci&#xf3;n y mejora del PAPPS (semFYC).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez-Lama</LastName><ForeName>Jes&#xfa;s</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Grupo de evaluaci&#xf3;n y mejora del PAPPS (semFYC); Instituto Maim&#xf3;nides de Investigaci&#xf3;n Biom&#xe9;dica de C&#xf3;rdoba (IMIBIC), Hospital Universitario Reina Sof&#xed;a, Universidad de C&#xf3;rdoba, C&#xf3;rdoba, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romero-Rodr&#xed;guez</LastName><ForeName>Esperanza</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Grupo de evaluaci&#xf3;n y mejora del PAPPS (semFYC); Instituto Maim&#xf3;nides de Investigaci&#xf3;n Biom&#xe9;dica de C&#xf3;rdoba (IMIBIC), Hospital Universitario Reina Sof&#xed;a, Universidad de C&#xf3;rdoba, C&#xf3;rdoba, Espa&#xf1;a. Electronic address: espe_mrr@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xe9;rula de Torres</LastName><ForeName>Luis &#xc1;ngel</ForeName><Initials>L&#xc1;</Initials><AffiliationInfo><Affiliation>Grupo de evaluaci&#xf3;n y mejora del PAPPS (semFYC); Instituto Maim&#xf3;nides de Investigaci&#xf3;n Biom&#xe9;dica de C&#xf3;rdoba (IMIBIC), Hospital Universitario Reina Sof&#xed;a, Universidad de C&#xf3;rdoba, C&#xf3;rdoba, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camarelles Guill&#xe9;n</LastName><ForeName>Francisco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>PAPPS y Grupo de educaci&#xf3;n para la salud del PAPPS (semFYC).</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>An&#xe1;lisis de la situaci&#xf3;n, evaluaci&#xf3;n y propuestas de mejora del Programa de Actividades Preventivas y de Promoci&#xf3;n de la Salud (PAPPS).</VernacularTitle></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Aten Primaria</MedlineTA><NlmUniqueID>9111075</NlmUniqueID><ISSNLinking>0212-6567</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006293" MajorTopicYN="Y">Health Promotion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011320" MajorTopicYN="Y">Primary Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015397" MajorTopicYN="N">Program Evaluation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="OBJETIVO">Analizar la situaci&#xf3;n, evaluaci&#xf3;n y propuestas de mejora del Programa de Actividades Preventivas y de Promoci&#xf3;n de la Salud (PAPPS).</AbstractText><AbstractText Label="MATERIAL Y M&#xc9;TODOS">Se realiz&#xf3; un estudio cualitativo de an&#xe1;lisis de la situaci&#xf3;n para una evaluaci&#xf3;n del PAPPS en 2 fases: 1) generaci&#xf3;n de ideas y recogida de informaci&#xf3;n a trav&#xe9;s de una matriz DAFO, a trav&#xe9;s de 2 tipos de criterios, internos (fortalezas y debilidades), y externos (amenazas y oportunidades); 2) priorizaci&#xf3;n de las propuestas de mejora recogidas. Selecci&#xf3;n de participantes: se identificaron informadores-clave teniendo en cuenta su relaci&#xf3;n y conocimiento del programa PAPPS. Se incluyeron a todos los integrantes de los grupos de expertos del PAPPS y miembros con participaci&#xf3;n en el pasado, as&#xed; como a los componentes del organismo de coordinaci&#xf3;n, incluidos los responsables auton&#xf3;micos del PAPPS. Se enviaron dos invitaciones a participar en el estudio: la primera desde el 29 diciembre de 2017 al 11 febrero de 2018, y la segunda entre el 10 y el 23 de enero de 2019. La informaci&#xf3;n se obtuvo a partir de un cuestionario concebido para ser autocumplimentado.</AbstractText><AbstractText Label="RESULTADOS Y CONCLUSIONES">Respondieron el cuestionario un total de 73 sujetos. El 35% de los participantes eran miembros de los grupos de trabajo del PAPPS, siendo el grupo m&#xe1;s numeroso, seguido de m&#xe9;dicos de familia de otros &#xe1;mbitos, con el 20,5%. El orden de priorizaci&#xf3;n de las propuestas de mejora fue el siguiente: 1) unificar recomendaciones con otros grupos de trabajo de semFYC; 2) elaborar listados con &#xab;Recomendaciones No hacer&#xbb; desde el punto de vista de la prevenci&#xf3;n; 3) incorporar el PAPPS en la agenda pol&#xed;tica; 4) mayor coordinaci&#xf3;n e interacci&#xf3;n entre grupos con competencias comunes; 5) docencia en pregrado y en unidades docentes, darse a conocer tambi&#xe9;n a los estudiantes de Medicina; 6) revisi&#xf3;n, actualizaci&#xf3;n y difusi&#xf3;n a cualquier profesional de Atenci&#xf3;n Primaria.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 The Authors. Publicado por Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Atenci&#xf3;n Primaria</Keyword><Keyword MajorTopicYN="N">Evaluation program</Keyword><Keyword MajorTopicYN="N">Health Promotion</Keyword><Keyword MajorTopicYN="N">Prevenci&#xf3;n</Keyword><Keyword MajorTopicYN="N">Prevention</Keyword><Keyword MajorTopicYN="N">Primary care</Keyword><Keyword MajorTopicYN="N">Programa de evaluaci&#xf3;n</Keyword><Keyword MajorTopicYN="N">Promoci&#xf3;n de salud</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>3</Day><Hour>20</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>12</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33388114</ArticleId><ArticleId IdType="pmc">PMC7801191</ArticleId><ArticleId IdType="doi">10.1016/j.aprim.2020.09.002</ArticleId><ArticleId IdType="pii">S0212-6567(20)30281-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Programa de Actividades Preventivas y de Promoci&#xf3;n de la Salud (PAPPS). Sociedad Espa&#xf1;ola de Medicina Familia y Comunitaria (semFYC); 2018. [Internet]. [consultado 23 Jun 2020]. Disponible en: http://www.papps.org/.</Citation></Reference><Reference><Citation>Canadian Task Force on Preventive Health Care; 2020. [Internet]. [consultado 23 Jun 2020]. Disponible en: http://www.ctfphc.org/.</Citation></Reference><Reference><Citation>United States Preventive Services Task Force (USPSTF); 2020. [Internet]. [consultado 23 Jun 2020]. Disponible en: http://www., ahrq., gov/clinic/uspstfix., htm.,</Citation></Reference><Reference><Citation>P&#xe9;rula de Torres L.A., Alonso Arias S., Bauz&#xe0; Nicolai K., Est&#xe9;vez J.C., Iglesias Rodal M., Mart&#xed;n Carrillo P. Opiniones de los profesionales sanitarios sobre la influencia del Programa de Actividades Preventivas y de Promoci&#xf3;n de la Salud (PAPPS) en atenci&#xf3;n primaria. Aten Primaria. 2007;39(Suppl 3):5&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">19288693</ArticleId></ArticleIdList></Reference><Reference><Citation>Deming W.E. D&#xed;az de Santos.; Madrid: 1989. Calidad, productividad y competitividad: la salida de la crisis. ISBN 84-87189-22-9.</Citation></Reference><Reference><Citation>Campy L.F., Lapiedra M., Libran G. T&#xe9;cnicas &#xfa;tiles en gesti&#xf3;n cl&#xed;nica. In: Jim&#xe9;nez J., editor. Manual de gesti&#xf3;n para jefes de servicios cl&#xed;nicos. D&#xed;az Santos; Madrid: 2000. pp. 41&#x2013;70.</Citation></Reference><Reference><Citation>Socrative; 2020. [Internet]. [consultado 23 Jun 2020]. Disponible en: https://www.socrative.com/.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32207062</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>27</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1543-0154</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>5</Issue><PubDate><Year>2021</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of cancer education : the official journal of the American Association for Cancer Education</Title><ISOAbbreviation>J Cancer Educ</ISOAbbreviation></Journal><ArticleTitle>Awareness of the European Code Against Cancer of Family Medicine Residents and Nursing and Medicine Students in Spain.</ArticleTitle><Pagination><StartPage>1069</StartPage><EndPage>1074</EndPage><MedlinePgn>1069-1074</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s13187-020-01736-y</ELocationID><Abstract><AbstractText Label="UNLABELLED">Health professionals and students in training are key for early diagnosis of cancer. The objective of this study was to evaluate the awareness of Family Medicine (FM) residents and Medicine and Nursing undergraduate students in Spain regarding the European Code Against Cancer (ECAC). This was a descriptive, cross-sectional, and multicenter study.</AbstractText><AbstractText Label="LOCATION">Teaching Units of FM of Cordoba and Ceuta and Schools of Medicine and Nursing of the Universities of Cordoba and Francisco de Vitoria of Madrid (Spain).</AbstractText><AbstractText Label="PARTICIPANTS">residents of FM and Medicine and Nursing undergraduate Spanish students.</AbstractText><AbstractText Label="INTERVENTION">self-administered questionnaire to assess the awareness about the ECAC. A total of 651 subjects participated (52.4% [95% CI 48.5-56.2] Nursing students, 34% [95% CI 30.3-37.6] Medicine students, and 13.6% [95% CI 11.0-16.3] FM residents). Of the total subjects participated, 74.8% were women. Mean age: 22.34&#xa0;years (standard deviation, 4.68; range, 18-52; 95% CI, 21.98-22.70). A total of 76.8% (95% CI 73.5-80.1) declared to be unaware of the ECAC. Those referring to be aware of the ECAC mainly knew it through degree subjects (7.5% [95% CI 5.5.5-9.6]). Residents of FM (p&#x2009;&lt;&#x2009;0.001), older participants (p&#x2009;&lt;&#x2009;0.001), and those belonging to the Teaching Units (p&#x2009;=&#x2009;0.002) showed a better awareness of the ECAC. Our findings reveal the unawareness on the ECAC in three out of four participants. The access to the advice described in the ECAC through the Medicine and Nursing Schools and FM Teaching Units is poor. The awareness of the ECAC of postgraduate residents is higher than that the awareness of the undergraduate students.</AbstractText><CopyrightInformation>&#xa9; 2020. American Association for Cancer Education.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>P&#xe9;rula-de Torres</LastName><ForeName>Luis &#xc1;ngel</ForeName><Initials>L&#xc1;</Initials><AffiliationInfo><Affiliation>Instituto Maim&#xf3;nides de Investigaci&#xf3;n Biom&#xe9;dica de C&#xf3;rdoba (IMIBIC), Hospital Universitario Reina Sof&#xed;a, Universidad de C&#xf3;rdoba, Avda. Men&#xe9;ndez Pidal s/n, 14011, C&#xf3;rdoba, Spain. langel.perula.sspa@juntadeandalucia.es.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unidad Docente Multiprofesional de Atenci&#xf3;n Familiar y Comunitaria de C&#xf3;rdoba, C&#xf3;rdoba, Spain. langel.perula.sspa@juntadeandalucia.es.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Grupo de Evaluaci&#xf3;n y mejora del Programa de Actividades Preventivas y de Promoci&#xf3;n de la Salud (PAPPS), de la Sociedad Espa&#xf1;ola de Medicina Familiar y Comunitaria (semFYC), Barcelona, Spain. langel.perula.sspa@juntadeandalucia.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romero-Rodr&#xed;guez</LastName><ForeName>Esperanza</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Instituto Maim&#xf3;nides de Investigaci&#xf3;n Biom&#xe9;dica de C&#xf3;rdoba (IMIBIC), Hospital Universitario Reina Sof&#xed;a, Universidad de C&#xf3;rdoba, Avda. Men&#xe9;ndez Pidal s/n, 14011, C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Grupo de Evaluaci&#xf3;n y mejora del Programa de Actividades Preventivas y de Promoci&#xf3;n de la Salud (PAPPS), de la Sociedad Espa&#xf1;ola de Medicina Familiar y Comunitaria (semFYC), Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Boston University School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moscosio-Cuevas</LastName><ForeName>Jos&#xe9; Ignacio</ForeName><Initials>JI</Initials><AffiliationInfo><Affiliation>Unidad Docente Multiprofesional de Atenci&#xf3;n Familiar y Comunitaria de C&#xf3;rdoba, C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruiz-Moral</LastName><ForeName>Roger</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Instituto Maim&#xf3;nides de Investigaci&#xf3;n Biom&#xe9;dica de C&#xf3;rdoba (IMIBIC), Hospital Universitario Reina Sof&#xed;a, Universidad de C&#xf3;rdoba, Avda. Men&#xe9;ndez Pidal s/n, 14011, C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidad Francisco de Vitoria, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jim&#xe9;nez-Garc&#xed;a</LastName><ForeName>Celia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Instituto Maim&#xf3;nides de Investigaci&#xf3;n Biom&#xe9;dica de C&#xf3;rdoba (IMIBIC), Hospital Universitario Reina Sof&#xed;a, Universidad de C&#xf3;rdoba, Avda. Men&#xe9;ndez Pidal s/n, 14011, C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Distrito Sanitario C&#xf3;rdoba y Guadalquivir, C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ranchal-Sanchez</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Instituto Maim&#xf3;nides de Investigaci&#xf3;n Biom&#xe9;dica de C&#xf3;rdoba (IMIBIC), Hospital Universitario Reina Sof&#xed;a, Universidad de C&#xf3;rdoba, Avda. Men&#xe9;ndez Pidal s/n, 14011, C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palenzuela-Paniagua</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Teaching Unit of Family and Community Medicine of Ceuta, Ceuta, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Group of the Adolescent, Andalusian Society of Family and Community Medicine (SAMFyC), Calle Al-Andalus, 21, 14011, C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Cancer Educ</MedlineTA><NlmUniqueID>8610343</NlmUniqueID><ISSNLinking>0885-8195</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005194" MajorTopicYN="N">Family Practice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="Y">Neoplasms</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013337" MajorTopicYN="Y">Students, Medical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013338" MajorTopicYN="Y">Students, Nursing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cancer prevention</Keyword><Keyword MajorTopicYN="N">European Code Against Cancer</Keyword><Keyword MajorTopicYN="N">Healthcare professionals</Keyword><Keyword MajorTopicYN="N">Primary Care</Keyword><Keyword MajorTopicYN="N">Undergraduate students</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32207062</ArticleId><ArticleId IdType="doi">10.1007/s13187-020-01736-y</ArticleId><ArticleId IdType="pii">10.1007/s13187-020-01736-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cancer figures in Spain (2018) Spanish Society of Medical Oncology Available from: https://congresoseom.org/dmcancer/wp-content/uploads/2018/01/Las_Cifras_del_cancer_en_Espana2018.pdf; [Accessed 10 Jan 2020]</Citation></Reference><Reference><Citation>New Global Cancer Data: GLOBOCAN 2018 (2018) Available from: https://www.uicc.org/new-global-cancer-data-globocan-2018; [Accessed 10 Jan 2020]</Citation></Reference><Reference><Citation>Commission of the European Community (1987) Europe against cancer action plan, 1987&#x2013;1989. Official J Eur Community. 87/C50/01:1&#x2013;58</Citation></Reference><Reference><Citation>Sch&#xfc;z J, Espina C, Villain P, Herrero R, Leon ME, Minozzi S et al (2015) European Code Against Cancer 4th edition: 12 ways to reduce your cancer risk. Cancer Epidemiol 39:S1&#x2013;S10. https://doi.org/10.1016/j.canep.2015.05.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canep.2015.05.009</ArticleId><ArticleId IdType="pubmed">26164654</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministerio de Sanidad, Servicios Sociales e Igualdad (2013) Informe del grupo de expertos sobre concreci&#xf3;n de cartera com&#xfa;n de servicios para cribado de c&#xe1;ncer Available from: https://www.mscbs.gob.es/profesionales/saludPublica/prevPromocion/cribadoCancer.htm ; [Accessed 10 Jan 2020]</Citation></Reference><Reference><Citation>Marzo-Castillejo M, Vela-Vallesp&#xed;n C, Bellas-Beceiro B, Bartolom&#xe9;-Moreno C, Mel&#xfa;s-Palaz&#xf3;n E, Vilarrub&#xed;-Estrella M et al (2018) Recomendaciones de prevenci&#xf3;n del c&#xe1;ncer. Actualizaci&#xf3;n PAPPS 2018. Aten Primaria 50(Supl 1):41&#x2013;65. https://doi.org/10.1016/S0212-6567(18)30362-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0212-6567(18)30362-7</ArticleId><ArticleId IdType="pubmed">29866358</ArticleId><ArticleId IdType="pmc">6837141</ArticleId></ArticleIdList></Reference><Reference><Citation>Janik-Koncewicz K, Ritchie D, Blicharz U, Zato&#x144;ski W (2017) Towards systematic evaluation of the European Code Against Cancer. Dissemination of the code in Poland. J Health Inequal 3(2):162&#x2013;166</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/jhi.2017.74211</ArticleId></ArticleIdList></Reference><Reference><Citation>Jovanovi&#x107; GK, Kresi&#x107; G, Zezelj SP, Mi&#x107;ovi&#x107; V, Nadarevi&#x107; VS (2011) Cancer and cardiovascular diseases nutrition knowledge and dietary intake of medical students. Coll Antropol 35:765&#x2013;774</Citation><ArticleIdList><ArticleId IdType="pubmed">22053554</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez ML, del Valle MO, Cueto A (1994) Knowledge of the European Code Against Cancer in sixth-form pupils and teachers in Asturias (Spain). Eur J Cancer Prev 3:207&#x2013;213</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00008469-199403000-00006</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rula-de-Torres L&#xc1;, Marz&#xf3;-Castillejo M, Ranchal-S&#xe1;nchez A, Bartolom&#xe9;-Moreno C, Parras-Rejano JM, Bellas-Beceiro B (2015) European Code Against Cancer: what does the Spanish population know and think about its recommendations? Eur J Cancer Prev 24:69&#x2013;75. https://doi.org/10.1097/CEJ.0000000000000102</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CEJ.0000000000000102</ArticleId><ArticleId IdType="pubmed">25536298</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rula de Torres LA et al (2018) Conocimiento, conducta y actitud ante el C&#xf3;digo europeo contra el c&#xe1;ncer por parte de los profesionales sanitarios de atenci&#xf3;n primaria. Aten Primaria. https://doi.org/10.1016/j.aprim.2018.11.002</Citation></Reference><Reference><Citation>Garr D, Lackland D, Wilson D (2000) Prevention education and evaluation in U.S. medical schools: a status report. Acad Med 75:S14&#x2013;S21</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001888-200007001-00003</ArticleId></ArticleIdList></Reference><Reference><Citation>Programa de actividades preventivas y de promoci&#xf3;n de la salud (PAPPS) (2019) Grupos de trabajo Available from: http://papps.es/grupos_trabajo.php; [Accessed 10 Jan 2020]</Citation></Reference><Reference><Citation>Ramada-Rodilla JM, Serra-Pujadas C, Delcl&#xf3;s-Clanchet GL (2013) Adaptaci&#xf3;n cultural y validaci&#xf3;n de cuestionarios de salud: revisi&#xf3;n y recomendaciones metodol&#xf3;gicas. Salud p&#xfa;blica M&#xe9;x 55:57&#x2013;66</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0036-36342013000100009</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabeza E, Catal&#xe1;n G, Avell&#xe0; A, Llobera J, Pons O (1999) Conocimientos, creencias y actitudes de la poblaci&#xf3;n femenina de Mallorca respecto al c&#xe1;ncer. Rev Esp Salud Publica. 73:485&#x2013;495</Citation></Reference><Reference><Citation>Berlanga Gonz&#xe1;lez MA, Casado Alonso Y, Gonz&#xe1;lez Cuadrado MD, Ib&#xe1;&#xf1;ez P&#xe9;rez F (1996) Aguirre zabala Jaca JR, et al. Conocimientos y actitudes relacionados con la prevenci&#xf3;n del c&#xe1;ncer en la poblaci&#xf3;n atendida en un centro de salud. Aten Primaria 18:417&#x2013;424</Citation><ArticleIdList><ArticleId IdType="pubmed">9091046</ArticleId></ArticleIdList></Reference><Reference><Citation>Cialdella-Kam L, Sabado P, Bispeck MK et al (2012) Implementing cancer prevention into clinical practice. J Cancer Educ 27(2 Suppl):S136&#x2013;S143</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13187-012-0331-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Zapka JG, Luckmann R, Sulsky SI et al (2000) Cancer control knowledge, attitudes, and perceived skills among medical students. J Cancer Educ 15:73&#x2013;78</Citation><ArticleIdList><ArticleId IdType="pubmed">10879894</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkerson L, Lee M, Hodgson CS (2002) Evaluating curricular effects on medical students&#x2019; knowledge and self-perceived skills in cancer prevention. Acad Med 77(suppl 10):S51&#x2013;S53</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001888-200210001-00017</ArticleId></ArticleIdList></Reference><Reference><Citation>Barton MB, Bell P, Sabesan S, Koczwara B (2006) What should doctors know about cancer? Undergraduate medical education from a societal perspective. Lancet Oncol 7(7):596&#x2013;601</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(06)70760-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Asgarlou Z, Tehrani S, Asghari E et al (2016) Cervical Cancer Prevention Knowledge and Attitudes among Female University Students and Hospital Staff in Iran. Asian Pac J Cancer Prev 17(11):4921&#x2013;4927. https://doi.org/10.22034/APJCP.2016.17.11.4921</Citation><ArticleIdList><ArticleId IdType="doi">10.22034/APJCP.2016.17.11.4921</ArticleId><ArticleId IdType="pubmed">28032497</ArticleId><ArticleId IdType="pmc">5454697</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietrzyk &#x141;, Torres A, Denisow-Pietrzyk M, Torres K (2015) What do we know about education in colorectal Cancer prevention?-survey among 1130 medical students. J Cancer Educ 32(2):406&#x2013;412</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13187-015-0967-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Encuesta sobre la situaci&#xf3;n del M&#xe9;dico de Atenci&#xf3;n Primaria en Espa&#xf1;a en 2015 y las consecuencias de los recortes. Organizaci&#xf3;n M&#xe9;dica Colegial de Espa&#xf1;a (2015) Available from: https://www.aepap.org/sites/default/files/noticia/archivos-adjuntos/encuestaresultados-generalesdf.pdf ; [Accessed 10 Jan 2020]</Citation></Reference><Reference><Citation>Distribuci&#xf3;n de las peticiones de plazas MIR en 2018 (2018) Available from: http://www.cesm.org/wp-content/uploads/2018/05/Informe-MIR-2018.pdf; [Accessed 10 Jan 2020]</Citation></Reference><Reference><Citation>Instituto Nacional de Estad&#xed;stica (2018) Estad&#xed;stica de profesionales sanitarios colegiados. Available from: https://www.ine.es/dyngs/INEbase/es/operacion.htm?c=Estadistica_C&amp;cid=1254736176781&amp;menu=resultados&amp;idp=1254735573175; [Accessed 10 Jan 2020]</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>